HomeRMTI • NASDAQ
add
Rockwell Medical Inc
Previous close
$1.69
Day range
$1.60 - $1.72
Year range
$0.78 - $5.15
Market cap
55.78M USD
Avg Volume
2.04M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 16.07M | -37.79% |
Operating expense | 3.85M | -4.54% |
Net income | -1.49M | -534.99% |
Net profit margin | -9.28 | -797.74% |
Earnings per share | — | — |
EBITDA | -786.00K | -173.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.42M | 55.29% |
Total assets | 52.62M | -0.76% |
Total liabilities | 22.22M | -24.77% |
Total equity | 30.41M | — |
Shares outstanding | 34.43M | — |
Price to book | 1.92 | — |
Return on assets | -6.33% | — |
Return on capital | -7.60% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.49M | -534.99% |
Cash from operations | 1.84M | 27.88% |
Cash from investing | -103.00K | -106.00% |
Cash from financing | -650.00K | -131.48% |
Net change in cash | 1.09M | -79.10% |
Free cash flow | 1.51M | 473.42% |
About
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease.
The company's primary customers are dialysis providers. Wikipedia
Founded
1996
Headquarters
Website
Employees
244
